Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorWeill Medical College of Cornell University

About this trial

The investigators hypothesized that during the 9-week course of Engage \& Connect treatment there will be an increase in brain functions of the Positive Valence System which in turn will lead to reduction in suicidality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ages aged 50-80 [stratified so that 50% are older than 65]

Endorsement of Suicidal Ideation [Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders-5 (SCID-5) Suicide Item (Item 9) with a score of 2

Major Depressive Disorder as determined by the SCID-5

Depression Rating Scale [Montgomery-Åsberg Depression Rating Scale (MADRS)] score of 16 or greater.

Disqualifiers

Intent or plan to attempt suicide in the near future.

History or presence of psychiatric diagnoses other than major depressive disorder without psychotic features, generalized anxiety disorder, or specific phobia.

Use of psychotropic drugs or cholinesterase inhibitors other than use of 0.5 mg or less of lorazepam daily up to seven times per week.

Neurological disorders (dementias, amnestic and multidomain Mild Cognitive Impairment, Parkinson's disease, epilepsy, etc.).

Trial design

Design model

Parallel

Treatments tested in this trial

  • "Engage & Connect" Psychotherapy

    Behavioral

    9-weeks of weekly psychotherapy sessions focused on social reward exposure

  • Symptom Review and Psychoeducation (SRP)

    Behavioral

    9-weeks of weekly psychotherapy sessions focused on symptom review and psychoeducation about depression and aging

Treatment groups

128 Participants
are divided into 2 treatment groups
Group A: "Engage & Connect" PsychotherapyExperimental treatment 1 intervention
Group B: Symptom Review and Psychoeducation (SRP)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in resting state functional connectivity of the Positive Valence System

Change in resting state fMRI connectivity of functional networks representing structures previously associated with the Positive Valence System (Dorsal anterior cingulate cortex \[dACC\], the Subgenual Anterior Cingulate Cortex \[sgACC\], and the basal forebrain/nucleus accumbens \[NAcc\]). The investigators will also test between-network connectivity between the positive valence system and the default mode-, salience-, and fronto-parietal networks. Functional connectivity within- and between-network will be measured with a correlational score of 0 to 1, with 0 being the lowest and 1 being the highest.

Time frame
Baseline, midtreatment (week 6) and post treatment (week 9)
2

Change in STAR task reaction time following social feedback

"The Social Task for Assessment of Reward" is a computerized task that measures response to social rewards. Reaction time will be measures in milliseconds.

Time frame
Baseline, midtreatment (week 6), and post treatment (week 9)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Weill Medical College of Cornell University

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator